Mechanism of a arsenic-mediated cancer development
Mechanism of a arsenic-mediated cancer development
批准号:
16310037
负责人:
KATO Masashi
金额:
$4.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
世界上有1000多万人的饮用水中含有高浓度的砷(>;5 mg/l)。据报道,在流行病学研究中,人类皮肤、肺癌、肝癌或膀胱癌的发生风险增加。这些报告表明,砷是人体内的致癌物质。为了防止饮用砷污染水的人癌症的爆炸性增加,我们需要阐明砷致癌的机制以建立有效的治疗方法。c-RET原癌基因编码一种受体类型的酪氨酸。C-RET的配体是胶质细胞源性神经营养因子(GDNF),其信号转导对肾脏器官发生和肠神经发生起重要作用。Ret激酶是由点突变或基因重排激活的。原癌基因c-RET的胚系突变与多发性内分泌腺瘤2A型(MEN2A型)的发生有关。通过酪氨酸905和1062的自动磷酸化来增强致癌的RET活性对于转化是至关重要的。在本研究中,我们通过分析RET酪氨酸激酶的激活来阐明砷介导的癌症发生的机制。1)砷介导的RET-MEN2A酪氨酸激酶的过度激活。砷促进c-RET原癌基因产物的活性(c-RET蛋白酪氨酸激酶)。砷能激活RET癌基因产物(RET-MEN2A:C-RET,半胱氨酸634取代精氨酸)的激酶活性,通过基因突变使其活性增加3-10倍。2)砷促进c-RET中关键酪氨酸的自磷酸化。据报道,905和1062的酪氨酸自磷酸化对c-RET的激活至关重要。砷促进c-RET中905和1062个酪氨酸的自磷酸化。3)SOD1(超氧化物歧化酶1)对砷介导的RET激酶活性的影响。
英文摘要
More than ten million people in the world suffered drinking water with high concentration of arsenic (>5 mg/1). It is reported that a risk of cancer development in skin, lung, liver or bladder increases in human in epidemiological research. These reports suggest that arsenic is a carcinogen in the human. To prevent against an explosive increase of cancer in the people who drink arsenic-polluted water, we need to clarify the mechanism of arsenic-induced cancer for establishing effective therapies.The c-RET proto-oncogene encodes a receptor type tyrosine. Ligand of c-RET is glial cell line-derived neurotrophic factor (GDNF), and its signaling is essential for renal organogenesis and enteric neurogenesis. The Ret kinase is activated by point mutations or gene rearrangement. Germ line mutations of the c-RET proto-oncogene are associated with the development of multiple endocrine neoplasia type 2A (MEN2A). Enhancement of oncogenic RET activity through autophosphorylation of tyrosine 905 and tyrosine 1062 are crucially important for transformation.In this study, we clarified mechanism of arsenic-mediated cancer development through analysis of RET tyrosine kinase activation.1) Arsenic-mediated superactivation of RET-MEN2A tyrosine kinase.Arsenic promotes c-RET proto-oncogene product activity (c-RET protein tyrosine kinase). Arsenic superactivates kinase activity of RET oncogene product (RET-MEN2A: c-RET with cysteine 634 replaced arginine), in which kinase activity was 3-10 fold augmented by genetic mutation.2) Arsenic promoted autophosphorylation of key tyrosines for activation in c-RET.Autophosphorylation of tyrosines 905 and 1062 were reported to be crucially important for c-RET kinase activation. Arsenic promoted autophosphorylation of 905 and 1062 tyrosines in c-RET.3) Effect of SOD1 (superoxide dismutase 1) on arsenic-mediated RET kinase activation.We showed that SOD1 inhibited UV-mediated but not arsenic-mediated RET tyrosine kinase activity.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
A PKC-mediated backup mechanism of the MXXCW motif-linked switch for initiating tyrosine kinase activities.
用于启动酪氨酸激酶活性的 MXXCW 基序连接开关的 PKC 介导的备份机制。
DOI:
--
发表时间:
2006
期刊:
FEBS letter 580
影响因子:
--
作者:
[Takeda, K. et al.]
通讯作者:
K. et al.
Molecular Mechanism of Iron Sensing by HapX, the Master Regulator of Iron Homeostasis in Filamentous Fungi
-
批准号:19K05802
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2019
-
负责人:KATO Masashi
-
依托单位:
Molecular mechanisms of transcriptional activation and repression by the major transcription factor of iron homeostasis in filamentous fungi
-
批准号:16K07679
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2016
-
负责人:KATO Masashi
-
依托单位:
Elucidation of effects of point defects on electrical properties of 4H-SiC and development of nrocesses for carrier lifetime control
-
批准号:23760012
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2011
-
负责人:KATO Masashi
-
依托单位:
Iron homeostasis regulated by the CCAAT-binding complex in filamentous fungi.
-
批准号:22580080
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2010
-
负责人:KATO Masashi
-
依托单位:
Analysis of arsenic-mediated carcinogenesis and development of a preventive therapy targeting modulation for three-dimensional structure of oncogene products.
-
批准号:20406003
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.49万
-
财政年份:2008
-
负责人:KATO Masashi
-
依托单位:
An Overview image of the transcription network regulated by the CCAAT binding complex in Aspergillus oryzae
-
批准号:19580088
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2007
-
负责人:KATO Masashi
-
依托单位:
Identification of defects degrading SiC device performance by the excess carrier lifetime mapping with micrometer resolution
-
批准号:19760215
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.45万
-
财政年份:2007
-
负责人:KATO Masashi
-
依托单位:
Assembly and sorting mechanisms of CCAAT-box binding complex of filamentous fungi
-
批准号:16580057
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2004
-
负责人:KATO Masashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
诱导自噬的FLT3/RET双靶点药物设计、合成及抗耐药性AML研究
-
批准号:82560677
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:黄强
-
依托单位:
基于机器学习与分子模拟的新型靶向RET激酶抑制剂筛选与抗肿瘤活性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:左柯
-
依托单位:
颗粒物通过肠胶质细胞GDNF/RET信号影响炎症性肠病的机制研究
-
批准号:82560635
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:柏桦
-
依托单位:
基于RET理论模型下的曼陀罗彩绘疗法在老年HIV/AIDS患者中的心理干预研究
-
批准号:2025JJ80476
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:余一知
-
依托单位:
基于肥大细胞外泌体介导GDNF/RET轴探讨健脾理气方缓解功能性消化不良内脏高敏感的机制研究
-
批准号:82505434
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:朱春洋
-
依托单位:
克服突变耐药的新型RET抑制剂的设计、合成及抗肿瘤活性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:彭丽洁
-
依托单位:
甘草酚通过肠胶质细胞GDNF/RET途径促进ZO-1与肠上皮细胞膜融合保护肠粘膜机械屏障的作用与机制研究
-
批准号:82304147
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:路上云
-
依托单位:
RET基因M918T突变通过JAK/STAT3信号通路轴调控腱糖蛋白C表达促进甲状腺髓样癌细胞干性的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:史潇
-
依托单位:
RET-M918T突变通过调控Tenascin C-EGFR复合体形成促进甲状腺髓样癌干性和侵袭转移的机制研究
-
批准号:82373008
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:史潇
-
依托单位:
SPP1+巨噬细胞促肺癌细胞MET活化介导RET抑制剂耐药的机制研究
-
批准号:82303643
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:鲁畅
-
依托单位: